← Browse by Condition
Medical Condition

neurasthenia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 4
NCT06843044 Phase 4
Recruiting

Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders

Enrollment
250 pts
Location
Russia
Sponsor
Valenta Pharm JSC
View Trial →